Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Using Mesenchymal Stem Cells With Therapeutic Hypothermia in Infants With Perinatal Hypoxic-Ischemic Encephalopathy: A Double Blind, Randomized Controlled Trial

NCT07018739 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT07018739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07018739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Using Mesenchymal Stem Cells With Therapeutic Hypothermia in Infants With Perinatal Hypoxic-Ischemic Encephalopathy: A Double Blind, Randomized Controlled Trial
Lead sponsor
Mahidol University
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
September 15, 2026
Completion date
December 31, 2033
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain injuries, hypoxic-ischemic, hypoxic-ischemic encephalopathy, neonatal